| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 4 | 2019 | 1076 | 1.200 |
Why?
|
| Dioctyl Sulfosuccinic Acid | 3 | 2019 | 15 | 0.920 |
Why?
|
| Inflammation | 2 | 2020 | 1030 | 0.870 |
Why?
|
| Surface-Active Agents | 3 | 2019 | 57 | 0.810 |
Why?
|
| Petroleum | 3 | 2017 | 14 | 0.800 |
Why?
|
| Environmental Exposure | 3 | 2020 | 269 | 0.760 |
Why?
|
| Petroleum Pollution | 2 | 2019 | 6 | 0.720 |
Why?
|
| Holistic Health | 1 | 2020 | 10 | 0.710 |
Why?
|
| Carcinogens, Environmental | 1 | 2020 | 16 | 0.710 |
Why?
|
| Mice | 34 | 2021 | 8474 | 0.650 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 37 | 0.630 |
Why?
|
| Adiposity | 1 | 2019 | 88 | 0.620 |
Why?
|
| PPAR gamma | 2 | 2016 | 95 | 0.620 |
Why?
|
| Dyslipidemias | 1 | 2019 | 98 | 0.610 |
Why?
|
| Alveolar Epithelial Cells | 4 | 2021 | 28 | 0.590 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 154 | 0.590 |
Why?
|
| Hexoses | 1 | 2016 | 5 | 0.550 |
Why?
|
| Emulsifying Agents | 1 | 2016 | 5 | 0.550 |
Why?
|
| Cryopreservation | 2 | 2014 | 103 | 0.540 |
Why?
|
| Transcriptional Activation | 2 | 2017 | 226 | 0.540 |
Why?
|
| Food | 1 | 2016 | 52 | 0.530 |
Why?
|
| Animals | 40 | 2021 | 20881 | 0.510 |
Why?
|
| Transcription Factors | 7 | 2016 | 753 | 0.450 |
Why?
|
| Mutation | 4 | 2020 | 1213 | 0.450 |
Why?
|
| Lung | 3 | 2021 | 849 | 0.440 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 86 | 0.420 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 492 | 0.410 |
Why?
|
| Mammary Glands, Animal | 3 | 2014 | 71 | 0.400 |
Why?
|
| Epithelial Cells | 6 | 2020 | 431 | 0.400 |
Why?
|
| Energy Metabolism | 3 | 2021 | 222 | 0.390 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2004 | 411 | 0.350 |
Why?
|
| Mice, Obese | 2 | 2013 | 33 | 0.350 |
Why?
|
| Trans-Activators | 5 | 2016 | 237 | 0.350 |
Why?
|
| Genes, Homeobox | 2 | 2003 | 15 | 0.340 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 3 | 2007 | 65 | 0.340 |
Why?
|
| Water Pollutants, Chemical | 3 | 2019 | 328 | 0.340 |
Why?
|
| Homeodomain Proteins | 4 | 2008 | 157 | 0.330 |
Why?
|
| Cell Differentiation | 7 | 2015 | 1034 | 0.330 |
Why?
|
| Neoplasms | 1 | 2020 | 1667 | 0.320 |
Why?
|
| Mice, Knockout | 10 | 2015 | 1692 | 0.320 |
Why?
|
| Alligators and Crocodiles | 2 | 2019 | 24 | 0.310 |
Why?
|
| Homeostasis | 3 | 2015 | 291 | 0.310 |
Why?
|
| Lactic Acid | 2 | 2021 | 86 | 0.310 |
Why?
|
| DNA-Binding Proteins | 5 | 2004 | 700 | 0.290 |
Why?
|
| Thymus Gland | 1 | 2007 | 97 | 0.280 |
Why?
|
| Spleen | 2 | 2007 | 301 | 0.280 |
Why?
|
| Lymphocytes | 2 | 2007 | 228 | 0.280 |
Why?
|
| Hematopoiesis | 3 | 2003 | 108 | 0.280 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 6 | 2010 | 106 | 0.270 |
Why?
|
| Multigene Family | 3 | 2003 | 93 | 0.270 |
Why?
|
| 3T3-L1 Cells | 2 | 2016 | 30 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 10 | 2019 | 2791 | 0.260 |
Why?
|
| SOXC Transcription Factors | 2 | 2015 | 4 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2020 | 756 | 0.260 |
Why?
|
| Lipids | 2 | 2017 | 298 | 0.250 |
Why?
|
| Genetic Markers | 2 | 2011 | 144 | 0.240 |
Why?
|
| Estrogens | 3 | 2019 | 173 | 0.230 |
Why?
|
| Colon | 2 | 2020 | 168 | 0.230 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 4 | 2014 | 24 | 0.230 |
Why?
|
| Pulmonary Alveoli | 3 | 2015 | 62 | 0.230 |
Why?
|
| Mice, Inbred Strains | 2 | 2003 | 181 | 0.230 |
Why?
|
| Embryonic Development | 2 | 2019 | 100 | 0.230 |
Why?
|
| Embryonic and Fetal Development | 4 | 2000 | 74 | 0.220 |
Why?
|
| Prostatic Neoplasms | 3 | 2016 | 778 | 0.220 |
Why?
|
| Lymphopoiesis | 1 | 2003 | 16 | 0.220 |
Why?
|
| Cell Proliferation | 6 | 2020 | 1174 | 0.220 |
Why?
|
| Genes, Lethal | 4 | 2014 | 16 | 0.220 |
Why?
|
| Hematologic Neoplasms | 1 | 2003 | 37 | 0.210 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2021 | 11 | 0.200 |
Why?
|
| Pulmonary Surfactants | 1 | 2021 | 41 | 0.200 |
Why?
|
| Body Patterning | 2 | 2000 | 44 | 0.190 |
Why?
|
| Mice, Transgenic | 5 | 2016 | 1033 | 0.190 |
Why?
|
| Pregnancy | 6 | 2019 | 2334 | 0.190 |
Why?
|
| Steroids | 1 | 2021 | 84 | 0.190 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 66 | 0.190 |
Why?
|
| Fetal Death | 1 | 2000 | 49 | 0.180 |
Why?
|
| Adherens Junctions | 1 | 2020 | 13 | 0.180 |
Why?
|
| PPAR delta | 1 | 2020 | 14 | 0.180 |
Why?
|
| Morphogenesis | 1 | 2000 | 159 | 0.180 |
Why?
|
| Humans | 21 | 2021 | 68618 | 0.170 |
Why?
|
| Oxygen | 1 | 2021 | 386 | 0.170 |
Why?
|
| Repressor Proteins | 1 | 2000 | 183 | 0.170 |
Why?
|
| Environmental Restoration and Remediation | 1 | 2019 | 18 | 0.170 |
Why?
|
| Cyclooxygenase 2 | 1 | 2020 | 160 | 0.170 |
Why?
|
| Breast Neoplasms | 3 | 2005 | 1536 | 0.170 |
Why?
|
| Endocrine Disruptors | 1 | 2019 | 31 | 0.170 |
Why?
|
| RNA Interference | 1 | 2020 | 266 | 0.160 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 36 | 0.160 |
Why?
|
| Heterozygote | 4 | 2013 | 174 | 0.160 |
Why?
|
| RNA, Messenger | 8 | 2021 | 1664 | 0.160 |
Why?
|
| Transcription, Genetic | 4 | 2008 | 562 | 0.160 |
Why?
|
| Hemorrhage | 1 | 2000 | 328 | 0.160 |
Why?
|
| Cell Line | 6 | 2021 | 1752 | 0.150 |
Why?
|
| Feminization | 1 | 2017 | 1 | 0.150 |
Why?
|
| Sex Determination Processes | 1 | 2017 | 6 | 0.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 240 | 0.150 |
Why?
|
| Models, Animal | 2 | 2014 | 252 | 0.150 |
Why?
|
| Base Sequence | 6 | 2010 | 1015 | 0.150 |
Why?
|
| Gene Expression Regulation | 7 | 2017 | 1293 | 0.150 |
Why?
|
| Nuclear Proteins | 3 | 2016 | 271 | 0.150 |
Why?
|
| Oxygen Consumption | 2 | 2015 | 258 | 0.140 |
Why?
|
| Recombination, Genetic | 2 | 2000 | 62 | 0.140 |
Why?
|
| Signal Transduction | 5 | 2020 | 2689 | 0.140 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2016 | 13 | 0.140 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 498 | 0.140 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2016 | 25 | 0.140 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 34 | 0.140 |
Why?
|
| Daphnia | 1 | 2016 | 12 | 0.140 |
Why?
|
| Adipogenesis | 1 | 2016 | 17 | 0.140 |
Why?
|
| Oleic Acid | 1 | 2016 | 40 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 78 | 0.140 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2016 | 18 | 0.140 |
Why?
|
| Gene Targeting | 4 | 2014 | 58 | 0.130 |
Why?
|
| Genotype | 3 | 2014 | 786 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2016 | 235 | 0.130 |
Why?
|
| Prostate | 1 | 2016 | 116 | 0.130 |
Why?
|
| Cerebellar Ataxia | 1 | 2015 | 8 | 0.130 |
Why?
|
| Adipocytes | 1 | 2016 | 88 | 0.130 |
Why?
|
| Alkaline Ceramidase | 1 | 2015 | 35 | 0.130 |
Why?
|
| Cell Communication | 2 | 2014 | 116 | 0.130 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 120 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2016 | 326 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 108 | 0.120 |
Why?
|
| Untranslated Regions | 1 | 2014 | 1 | 0.120 |
Why?
|
| Perinatal Death | 1 | 2014 | 4 | 0.120 |
Why?
|
| Penetrance | 1 | 2014 | 17 | 0.120 |
Why?
|
| Tissue Banks | 1 | 2014 | 13 | 0.120 |
Why?
|
| Cell Survival | 2 | 2014 | 901 | 0.120 |
Why?
|
| Fibroblasts | 3 | 2014 | 902 | 0.120 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 284 | 0.120 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 62 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 1173 | 0.120 |
Why?
|
| Transcription Factor CHOP | 1 | 2014 | 28 | 0.120 |
Why?
|
| Killer Cells, Natural | 2 | 2004 | 94 | 0.120 |
Why?
|
| Cryoprotective Agents | 1 | 2014 | 31 | 0.120 |
Why?
|
| Protein Stability | 1 | 2014 | 90 | 0.120 |
Why?
|
| RNA Stability | 1 | 2014 | 55 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2000 | 328 | 0.110 |
Why?
|
| Female | 14 | 2020 | 38074 | 0.110 |
Why?
|
| Thrombin | 1 | 2014 | 117 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 148 | 0.110 |
Why?
|
| Glucose | 1 | 2015 | 307 | 0.110 |
Why?
|
| Lactation | 1 | 2014 | 110 | 0.110 |
Why?
|
| Phenotype | 4 | 2014 | 947 | 0.110 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 1447 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 163 | 0.100 |
Why?
|
| Up-Regulation | 3 | 2010 | 682 | 0.100 |
Why?
|
| Proteomics | 1 | 2014 | 246 | 0.100 |
Why?
|
| Growth Substances | 1 | 1991 | 77 | 0.100 |
Why?
|
| Whales | 1 | 2011 | 6 | 0.100 |
Why?
|
| DNA Mutational Analysis | 1 | 1991 | 159 | 0.100 |
Why?
|
| Primary Cell Culture | 1 | 2011 | 56 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 627 | 0.090 |
Why?
|
| Vaccinia virus | 1 | 1991 | 97 | 0.090 |
Why?
|
| Male | 10 | 2020 | 37321 | 0.090 |
Why?
|
| Mitochondria | 1 | 2015 | 643 | 0.090 |
Why?
|
| Thrombocytopenia | 1 | 2010 | 122 | 0.090 |
Why?
|
| Hemoglobins | 1 | 2010 | 120 | 0.090 |
Why?
|
| Crosses, Genetic | 2 | 2003 | 60 | 0.090 |
Why?
|
| Aging | 1 | 2015 | 911 | 0.080 |
Why?
|
| Apoptosis | 2 | 2014 | 1641 | 0.080 |
Why?
|
| Brain | 2 | 2015 | 2176 | 0.080 |
Why?
|
| Hypoxia | 1 | 2010 | 169 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2008 | 46 | 0.080 |
Why?
|
| Cell Hypoxia | 3 | 2015 | 92 | 0.080 |
Why?
|
| Sex Ratio | 2 | 2019 | 13 | 0.080 |
Why?
|
| Lymphoid Tissue | 1 | 2008 | 30 | 0.080 |
Why?
|
| Transfection | 4 | 2010 | 782 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-ets | 3 | 2004 | 79 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2014 | 2673 | 0.080 |
Why?
|
| Alleles | 1 | 2008 | 386 | 0.070 |
Why?
|
| Carcinogenesis | 2 | 2020 | 124 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 51 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 38 | 0.070 |
Why?
|
| Antiporters | 1 | 2006 | 5 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2000 | 312 | 0.070 |
Why?
|
| Chlorides | 1 | 2006 | 68 | 0.070 |
Why?
|
| Somites | 1 | 2006 | 6 | 0.070 |
Why?
|
| Endoderm | 1 | 2006 | 37 | 0.070 |
Why?
|
| DNA Primers | 3 | 2010 | 302 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 329 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2007 | 246 | 0.070 |
Why?
|
| HeLa Cells | 2 | 2010 | 237 | 0.070 |
Why?
|
| DNA | 1 | 2008 | 597 | 0.070 |
Why?
|
| Hyaluronan Receptors | 1 | 2007 | 142 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2010 | 322 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 248 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 786 | 0.060 |
Why?
|
| Granulocytes | 1 | 2004 | 22 | 0.060 |
Why?
|
| Models, Biological | 3 | 2021 | 981 | 0.060 |
Why?
|
| Barrett Esophagus | 1 | 2005 | 57 | 0.060 |
Why?
|
| Glycolysis | 2 | 2015 | 79 | 0.060 |
Why?
|
| Interleukin-15 | 1 | 2004 | 66 | 0.060 |
Why?
|
| Erythrocytes | 1 | 2004 | 137 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 150 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2004 | 133 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 147 | 0.060 |
Why?
|
| Esophageal Neoplasms | 1 | 2005 | 150 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 1851 | 0.060 |
Why?
|
| Embryo, Mammalian | 3 | 2014 | 176 | 0.060 |
Why?
|
| Immunophenotyping | 1 | 2003 | 110 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2004 | 447 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2005 | 742 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2008 | 307 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 1174 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 852 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 475 | 0.050 |
Why?
|
| Terbutaline | 1 | 2021 | 23 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2021 | 67 | 0.050 |
Why?
|
| A549 Cells | 1 | 2021 | 50 | 0.050 |
Why?
|
| Betamethasone | 1 | 2021 | 24 | 0.050 |
Why?
|
| Body Fluids | 1 | 2021 | 41 | 0.050 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2021 | 54 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1553 | 0.050 |
Why?
|
| Sheep | 1 | 2021 | 128 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 508 | 0.050 |
Why?
|
| Radiation Chimera | 1 | 2000 | 15 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 2550 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2021 | 150 | 0.050 |
Why?
|
| Fungal Proteins | 1 | 2000 | 37 | 0.050 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2000 | 49 | 0.050 |
Why?
|
| GATA1 Transcription Factor | 2 | 2010 | 19 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2000 | 124 | 0.050 |
Why?
|
| Nervous System | 1 | 2000 | 45 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2021 | 308 | 0.050 |
Why?
|
| Ribonuclease III | 1 | 2020 | 16 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2015 | 223 | 0.040 |
Why?
|
| Peripheral Nervous System | 1 | 1999 | 12 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2000 | 109 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2021 | 222 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2000 | 235 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2000 | 107 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 434 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2020 | 155 | 0.040 |
Why?
|
| Progesterone | 1 | 2000 | 115 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2000 | 164 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 1999 | 100 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 219 | 0.040 |
Why?
|
| Florida | 1 | 2019 | 221 | 0.040 |
Why?
|
| Locomotion | 1 | 1999 | 135 | 0.040 |
Why?
|
| In Situ Hybridization | 2 | 2000 | 201 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 2004 | 189 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 290 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2004 | 756 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 215 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2004 | 181 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2008 | 615 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 299 | 0.040 |
Why?
|
| Genes, Viral | 2 | 1991 | 44 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 142 | 0.040 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2016 | 5 | 0.040 |
Why?
|
| Toxicity Tests, Acute | 1 | 2016 | 4 | 0.030 |
Why?
|
| Toxicity Tests, Chronic | 1 | 2016 | 4 | 0.030 |
Why?
|
| Lethal Dose 50 | 1 | 2016 | 13 | 0.030 |
Why?
|
| Fresh Water | 1 | 2016 | 43 | 0.030 |
Why?
|
| Reproduction | 1 | 2016 | 48 | 0.030 |
Why?
|
| Ecosystem | 1 | 2016 | 54 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 2015 | 18 | 0.030 |
Why?
|
| beta Catenin | 1 | 2015 | 73 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 194 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2016 | 202 | 0.030 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2015 | 15 | 0.030 |
Why?
|
| Symporters | 1 | 2015 | 27 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2020 | 447 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2015 | 47 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 118 | 0.030 |
Why?
|
| Liver | 1 | 2000 | 1118 | 0.030 |
Why?
|
| Genes, Insect | 1 | 1994 | 4 | 0.030 |
Why?
|
| Breeding | 1 | 2014 | 15 | 0.030 |
Why?
|
| Embryo Loss | 1 | 1994 | 17 | 0.030 |
Why?
|
| Gene Order | 1 | 2014 | 13 | 0.030 |
Why?
|
| Embryo Implantation | 1 | 1994 | 17 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 659 | 0.030 |
Why?
|
| Drosophila | 1 | 1994 | 37 | 0.030 |
Why?
|
| Proton Ionophores | 1 | 2014 | 7 | 0.030 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2014 | 14 | 0.030 |
Why?
|
| Receptor, PAR-1 | 1 | 2014 | 30 | 0.030 |
Why?
|
| Glycogen | 1 | 2014 | 27 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 2014 | 47 | 0.030 |
Why?
|
| Lysophospholipids | 1 | 2015 | 209 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2008 | 481 | 0.030 |
Why?
|
| Transition Temperature | 1 | 2013 | 9 | 0.030 |
Why?
|
| Carbon | 1 | 2015 | 122 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2013 | 19 | 0.030 |
Why?
|
| Genetic Carrier Screening | 1 | 2013 | 25 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 331 | 0.030 |
Why?
|
| Organogenesis | 1 | 2014 | 49 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2004 | 489 | 0.030 |
Why?
|
| Sphingosine | 1 | 2015 | 315 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2014 | 99 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2014 | 233 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 219 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 189 | 0.030 |
Why?
|
| Chimera | 2 | 2004 | 33 | 0.030 |
Why?
|
| Weight Gain | 1 | 2013 | 135 | 0.030 |
Why?
|
| Stem Cells | 1 | 1994 | 248 | 0.030 |
Why?
|
| Sphingolipids | 1 | 2015 | 337 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 333 | 0.030 |
Why?
|
| Pulmonary Fibrosis | 1 | 2014 | 157 | 0.030 |
Why?
|
| Transcriptome | 1 | 2014 | 164 | 0.030 |
Why?
|
| Gene Expression | 1 | 2014 | 770 | 0.020 |
Why?
|
| Viral Plaque Assay | 1 | 1991 | 12 | 0.020 |
Why?
|
| Viral Structural Proteins | 1 | 1991 | 10 | 0.020 |
Why?
|
| Ceramides | 1 | 2015 | 578 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1991 | 38 | 0.020 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2011 | 8 | 0.020 |
Why?
|
| Procollagen | 1 | 2011 | 31 | 0.020 |
Why?
|
| Culture Media | 1 | 2011 | 155 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 2010 | 18 | 0.020 |
Why?
|
| Platelet Activation | 1 | 2010 | 24 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2010 | 45 | 0.020 |
Why?
|
| Erythroid Cells | 1 | 2010 | 5 | 0.020 |
Why?
|
| Platelet Count | 1 | 2010 | 100 | 0.020 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2010 | 11 | 0.020 |
Why?
|
| Heme | 1 | 2010 | 17 | 0.020 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2010 | 17 | 0.020 |
Why?
|
| Homozygote | 1 | 2010 | 119 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 166 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2014 | 718 | 0.020 |
Why?
|
| Microvilli | 1 | 2009 | 22 | 0.020 |
Why?
|
| Air | 1 | 2009 | 22 | 0.020 |
Why?
|
| Tight Junctions | 1 | 2009 | 25 | 0.020 |
Why?
|
| Polyurethanes | 1 | 2009 | 21 | 0.020 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2008 | 12 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 2455 | 0.020 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2008 | 3 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2008 | 7 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2008 | 19 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2008 | 17 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2008 | 40 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2008 | 15 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 189 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 483 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2008 | 43 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2008 | 89 | 0.020 |
Why?
|
| Genome, Human | 1 | 2008 | 62 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2011 | 384 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2008 | 168 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 1 | 2006 | 6 | 0.020 |
Why?
|
| Ion Transport | 1 | 2006 | 26 | 0.020 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2006 | 45 | 0.020 |
Why?
|
| Yolk Sac | 1 | 2006 | 10 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2006 | 43 | 0.020 |
Why?
|
| Time Factors | 2 | 2004 | 4655 | 0.020 |
Why?
|
| Exons | 1 | 2006 | 122 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2006 | 89 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2006 | 113 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 384 | 0.020 |
Why?
|
| Mesoderm | 1 | 2006 | 231 | 0.020 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2004 | 7 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2004 | 51 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2004 | 22 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 100 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2004 | 42 | 0.020 |
Why?
|
| Androstadienes | 1 | 2004 | 41 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2004 | 43 | 0.020 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2004 | 118 | 0.020 |
Why?
|
| Proteinuria | 1 | 2004 | 136 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 134 | 0.010 |
Why?
|
| Chemokines | 1 | 2004 | 119 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2004 | 149 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2004 | 146 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 217 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 532 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 216 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 21403 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 282 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 710 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 954 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2004 | 434 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 1056 | 0.010 |
Why?
|
| Avian Leukosis Virus | 1 | 1981 | 7 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1981 | 26 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 1753 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 57 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1981 | 114 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 866 | 0.010 |
Why?
|
| Spinal Nerves | 1 | 1999 | 3 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 12 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 200 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1999 | 60 | 0.010 |
Why?
|
| Hindlimb | 1 | 1999 | 38 | 0.010 |
Why?
|
| Spine | 1 | 1999 | 46 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2000 | 261 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 1196 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 376 | 0.010 |
Why?
|
| Gait | 1 | 1999 | 120 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1997 | 61 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1997 | 86 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1997 | 161 | 0.010 |
Why?
|
| Adolescent | 1 | 2005 | 8912 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1981 | 49 | 0.000 |
Why?
|
| Base Composition | 1 | 1981 | 22 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1981 | 357 | 0.000 |
Why?
|